The effects of orlistat on metabolic parameters and other cardiovascular risk factors

This publication has 46 references indexed in Scilit:

• XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
  Diabetes Care, 2004
• The Effect of Orlistat-Induced Weight Loss, Without Concomitant Hypocaloric Diet, on Cardiovascular Risk Factors and Insulin Sensitivity in Young Obese Chinese Subjects With or Without Type 2 Diabetes
  Archives of internal medicine (1960), 2002
• Orlistat: its current status as an anti-obesity drug
  European Journal of Pharmacology, 2002
• Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
• Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults
  Archives of internal medicine (1960), 2000
• Orlistat in the Long-term Treatment of Obesity in Primary Care Settings
  Archives of Family Medicine, 2000
• Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat
  JAMA, 1999
• Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
  Published by Elsevier ,1998
• The Effect of Orlistat on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers
  The Journal of Clinical Pharmacology, 1996
• Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers
  The Journal of Clinical Pharmacology, 1995